Part of the Healthcare Services sector
Core investment principles and frameworks for this industry
Capital allocation is central for US medical devices & diagnostics: buybacks, dividends, M&A, capex, and debt reduction must be judged against returns from the specific reinvestment cycle around procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability. Management teams that repurchase stock while underinvesting in core capacity can create short-term EPS growth but weaken long-term advantage.
Durable US winners in medical devices & diagnostics usually combine scale, data, distribution, switching costs, brand strength, regulatory approvals, or low-cost supply. The key question is whether those moats are widening in the latest 10-K, 10-Q, and earnings call evidence around procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability.
US-listed companies in medical devices & diagnostics often face federal and state oversight, antitrust review, tax-credit rules, tariff exposure, or agency-specific regulation. A strong thesis should identify which rules directly affect procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability, and which rules expand barriers to entry versus cap pricing, volumes, or returns.
For US medical devices & diagnostics, revenue quality depends on recurring demand, contract durability, customer concentration, and how clearly management reconciles segment performance in SEC filings. Analysts should separate one-time demand spikes from repeatable growth drivers tied to procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability.
US GAAP margins can hide important business-model shifts when mix, rebates, depreciation, stock compensation, or capitalized costs move faster than reported revenue. Track gross margin, operating leverage, cash conversion, and the operating KPIs tied to procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability to judge whether medical devices & diagnostics companies are compounding or only growing nominal sales.
Active trends shaping the industry landscape
Demand for US medical devices & diagnostics should be read through the industry-specific indicators behind procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability. A thesis should distinguish cyclical recovery from structural growth using volumes, pricing, backlog, bookings, usage, or guidance commentary that management discloses in SEC filings and earnings materials.
AI, automation, software, data analytics, and connected operations are changing cost structures across US medical devices & diagnostics. Companies that convert these tools into measurable productivity, pricing power, or share gains in procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability deserve different treatment from firms only using technology language in investor materials.
Consolidation, vertical integration, platform power, private-label competition, and new entrants are reshaping US medical devices & diagnostics. Track whether profit pools around procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability are moving toward scale leaders, low-cost operators, regulated incumbents, or specialist challengers.
Federal rules, state policy, tax incentives, agency approvals, procurement cycles, and antitrust enforcement can materially change US medical devices & diagnostics economics. The strongest analysis links policy changes to procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability, specific revenue pools, cost lines, and balance-sheet needs.
US companies are adapting to tariffs, reshoring incentives, supplier concentration, logistics disruption, and China exposure. Watch inventory days, gross margin bridges, sourcing disclosures, and capex location only where they affect the real economics of procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability.
Events and factors that could trigger significant change
Quarterly guidance, margin bridges, segment disclosures, and management tone can quickly reset expectations for US medical devices & diagnostics. Large revisions to metrics tied to procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability should be treated as first-order catalysts, especially when management changes full-year assumptions.
Changes in Fed policy influence discount rates, consumer credit, corporate capex, housing activity, and refinancing risk. For US medical devices & diagnostics, the rate-cycle catalyst matters most when financing conditions, capex appetite, or long-duration valuation assumptions change the outlook for procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability.
Spin-offs, acquisitions, divestitures, activist campaigns, and private-equity interest can reprice US medical devices & diagnostics. A good catalyst view compares strategic fit, leverage impact, synergy credibility, and regulatory approval risk under US antitrust review.
New products, capacity additions, platform launches, procurement awards, infrastructure builds, approvals, or manufacturing ramps can change the growth profile for US medical devices & diagnostics. Focus on timing, execution risk, and whether the spend tied to procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability earns returns above the cost of capital.
Tax credits, tariffs, agency decisions, antitrust actions, procurement rules, infrastructure programs, and state-level policy can alter economics for US medical devices & diagnostics. Analysts should map each policy catalyst to the companies most exposed to procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability rather than treating it as a broad macro headline.
Critical financial and operational metrics for evaluation
Net debt, liquidity, maturity schedule, pension obligations, and covenant flexibility determine whether US medical devices & diagnostics companies can invest through downturns. Higher-rate refinancing risk should be weighed against cash generation and the capital intensity of procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability.
Free cash flow after capex is the cleanest check on reported earnings for US medical devices & diagnostics. Watch working capital, lease obligations, capitalized software, maintenance capex, and cash taxes relative to the investment needs created by procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability.
Gross margin, operating margin, EBITDA margin, and segment margin reveal whether US medical devices & diagnostics firms have pricing power or only scale without profitability. Compare margin movement against the mix, input costs, depreciation, stock-based compensation, and operating leverage behind procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability.
Return on invested capital, asset turns, and reinvestment runway determine whether US medical devices & diagnostics companies create value while growing. ROIC should be compared with the weighted average cost of capital and with management's claims about reinvesting into procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability.
Track reported and organic revenue growth for US medical devices & diagnostics, separating price, volume, FX, acquisitions, and accounting changes. Durable growth should be visible in both GAAP revenue and supporting operating metrics tied to procedure volumes, FDA approvals, hospital capex, installed base pull-through, and gross margin durability in SEC filings or investor decks.
Allurion Technologies, Inc. Common Stock
NYSE:ALURNYSE
ALUR
Ekso Bionics Holdings, Inc. - Common Stock
NASDAQ:EKSONASDAQ
EKSO
Exact Sciences Corporation - Common Stock
NASDAQ:EXASNASDAQ
EXAS
Fonar Corporation - Common Stock
NASDAQ:FONRNASDAQ
FONR
Hologic, Inc. - Common Stock
NASDAQ:HOLXNASDAQ
HOLX
Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares
NASDAQ:IINNNASDAQ
IINN
Lyra Therapeutics, Inc. - Common Stock
NASDAQ:LYRANASDAQ
LYRA
Semler Scientific, Inc. - Common Stock
NASDAQ:SMLRNASDAQ
SMLR
Strata Skin Sciences, Inc. - Common Stock
NASDAQ:SSKNNASDAQ
SSKN
Sharps Technology Inc. - Common Stock
NASDAQ:STSSNASDAQ
STSS
Tivic Health Systems, Inc. - Common stock
NASDAQ:TIVCNASDAQ
TIVC
Venus Concept Inc. - Common Stock
NASDAQ:VERONASDAQ
VERO
Vicarious Surgical Inc. Class A Common Stock
NYSE:RBOTNYSE
RBOT
EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share
NASDAQ:EDAPNASDAQ
EDAP
Intuitive Surgical, Inc. - Common Stock
NASDAQ:ISRGNASDAQ
ISRG
Stryker Corporation Common Stock
NYSE:SYKNYSE
SYK
Medtronic plc. Ordinary Shares
NYSE:MDTNYSE
MDT
Boston Scientific Corporation Common Stock
NYSE:BSXNYSE
BSX
Edwards Lifesciences Corporation Common Stock
NYSE:EWNYSE
EW
IDEXX Laboratories, Inc. - Common Stock
NASDAQ:IDXXNASDAQ
IDXX
Medline Inc. - Class A common stock
NASDAQ:MDLNNASDAQ
MDLN
Becton, Dickinson and Company Common Stock
NYSE:BDXNYSE
BDX
Alcon Inc. Ordinary Shares
NYSE:ALCNYSE
ALC
GE HealthCare Technologies Inc. - Common Stock
NASDAQ:GEHCNASDAQ
GEHC
ResMed Inc. Common Stock
NYSE:RMDNYSE
RMD
DexCom, Inc. - Common Stock
NASDAQ:DXCMNASDAQ
DXCM
Koninklijke Philips N.V. NY Registry Shares
NYSE:PHGNYSE
PHG
West Pharmaceutical Services, Inc. Common Stock
NYSE:WSTNYSE
WST
STERIS plc (Ireland) Ordinary Shares
NYSE:STENYSE
STE
Zimmer Biomet Holdings, Inc. Common Stock
NYSE:ZBHNYSE
ZBH
Solventum Corporation Common Stock
NYSE:SOLVNYSE
SOLV
The Cooper Companies, Inc. - Common Stock
NASDAQ:COONASDAQ
COO
Smith & Nephew SNATS, Inc. Common Stock
NYSE:SNNNYSE
SNN
Penumbra, Inc. Common Stock
NYSE:PENNYSE
PEN
Align Technology, Inc. - Common Stock
NASDAQ:ALGNNASDAQ
ALGN
Globus Medical, Inc. Class A Common Stock
NYSE:GMEDNYSE
GMED
Insulet Corporation - Common Stock
NASDAQ:PODDNASDAQ
PODD
Baxter International Inc. Common Stock
NYSE:BAXNYSE
BAX
Masimo Corporation - Common Stock
NASDAQ:MASINASDAQ
MASI
Glaukos Corporation Common Stock
NYSE:GKOSNYSE
GKOS
Teleflex Incorporated Common Stock
NYSE:TFXNYSE
TFX
Stevanato Group S.p.A. Ordinary Shares
NYSE:STVNNYSE
STVN
Bausch + Lomb Corporation Common Shares
NYSE:BLCONYSE
BLCO
LivaNova PLC - Ordinary Shares
NASDAQ:LIVNNASDAQ
LIVN
Merit Medical Systems, Inc. - Common Stock
NASDAQ:MMSINASDAQ
MMSI
Envista Holdings Corporation Common Stock
NYSE:NVSTNYSE
NVST
iRhythm Technologies, Inc. - Common Stock
NASDAQ:IRTCNASDAQ
IRTC
ICU Medical, Inc. - Common Stock
NASDAQ:ICUINASDAQ
ICUI
Haemonetics Corporation Common Stock
NYSE:HAENYSE
HAE
Integer Holdings Corporation Common Stock
NYSE:ITGRNYSE
ITGR
Heartflow, Inc. - Common Stock
NASDAQ:HTFLNASDAQ
HTFL
TransMedics Group, Inc. - Common Stock
NASDAQ:TMDXNASDAQ
TMDX
Axogen, Inc. - Common Stock
NASDAQ:AXGNNASDAQ
AXGN
Establishment Labs Holdings Inc. - Common Shares
NASDAQ:ESTANASDAQ
ESTA
LeMaitre Vascular, Inc. - Common Stock
NASDAQ:LMATNASDAQ
LMAT
NovoCure Limited - Ordinary Shares
NASDAQ:NVCRNASDAQ
NVCR
DENTSPLY SIRONA Inc. - Common Stock
NASDAQ:XRAYNASDAQ
XRAY
Pulse Biosciences, Inc - Common Stock
NASDAQ:PLSENASDAQ
PLSE
UFP Technologies, Inc. - Common Stock
NASDAQ:UFPTNASDAQ
UFPT
PROCEPT BioRobotics Corporation - Common Stock
NASDAQ:PRCTNASDAQ
PRCT
STAAR Surgical Company - Common Stock
NASDAQ:STAANASDAQ
STAA
AtriCure, Inc. - Common Stock
NASDAQ:ATRCNASDAQ
ATRC
Tandem Diabetes Care, Inc. - Common Stock
NASDAQ:TNDMNASDAQ
TNDM
Enovis Corporation Common Stock
NYSE:ENOVNYSE
ENOV
BioLife Solutions, Inc. - Common Stock
NASDAQ:BLFSNASDAQ
BLFS
Integra LifeSciences Holdings Corporation - Common Stock
NASDAQ:IARTNASDAQ
IART
National Vision Holdings, Inc. - Common Stock
NASDAQ:EYENASDAQ
EYE
Alphatec Holdings, Inc. - Common Stock
NASDAQ:ATECNASDAQ
ATEC
Butterfly Network, Inc. Class A Common Stock
NYSE:BFLYNYSE
BFLY
iRadimed Corporation - Common Stock
NASDAQ:IRMDNASDAQ
IRMD
Inspire Medical Systems, Inc. Common Stock
NYSE:INSPNYSE
INSP
Avanos Medical, Inc. Common Stock
NYSE:AVNSNYSE
AVNS
Kestra Medical Technologies, Ltd. - Common Stock
NASDAQ:KMTSNASDAQ
KMTS
CONMED Corporation Common Stock
NYSE:CNMDNYSE
CNMD
Artivion, Inc. Common Stock
NYSE:AORTNYSE
AORT
QuidelOrtho Corporation - Common Stock
NASDAQ:QDELNASDAQ
QDEL
Anteris Technologies Global Corp. - Common Stock
NASDAQ:AVRNASDAQ
AVR
InMode Ltd. - Ordinary Shares
NASDAQ:INMDNASDAQ
INMD
Alpha Tau Medical Ltd. - Ordinary Shares
NASDAQ:DRTSNASDAQ
DRTS
SS Innovations International Inc. - Common Stock
NASDAQ:SSIINASDAQ
SSII
Bioventus Inc. - Class A Common Stock
NASDAQ:BVSNASDAQ
BVS
CeriBell, Inc. - Common Stock
NASDAQ:CBLLNASDAQ
CBLL
SI-BONE, Inc. - Common Stock
NASDAQ:SIBNNASDAQ
SIBN
Beta Bionics, Inc. - Common Stock
NASDAQ:BBNXNASDAQ
BBNX
Tactile Systems Technology, Inc. - Common Stock
NASDAQ:TCMDNASDAQ
TCMD
MiMedx Group, Inc - Common Stock
NASDAQ:MDXGNASDAQ
MDXG
BrainsWay Ltd. - American Depositary Shares
NASDAQ:BWAYNASDAQ
BWAY
Cerus Corporation - Common Stock
NASDAQ:CERSNASDAQ
CERS
Neuropace, Inc. - Common Stock
NASDAQ:NPCENASDAQ
NPCE
AngioDynamics, Inc. - Common Stock
NASDAQ:ANGONASDAQ
ANGO
OrthoPediatrics Corp. - Common Stock
NASDAQ:KIDSNASDAQ
KIDS
Orthofix Medical Inc. - Common Stock
NASDAQ:OFIXNASDAQ
OFIX
ClearPoint Neuro Inc. - Common Stock
NASDAQ:CLPTNASDAQ
CLPT
Delcath Systems, Inc. - Common Stock
NASDAQ:DCTHNASDAQ
DCTH
CapsoVision, Inc. - Common Stock
NASDAQ:CVNASDAQ
CV
Electromed, Inc. Common Stock
AMEX:ELMDAMEX
ELMD
Carlsmed, Inc. - Common Stock
NASDAQ:CARLNASDAQ
CARL
Shoulder Innovations, Inc. Common Stock
NYSE:SINYSE
SI
OraSure Technologies, Inc. - Common Stock
NASDAQ:OSURNASDAQ
OSUR
Senseonics Holdings, Inc. - Common Stock
NASDAQ:SENSNASDAQ
SENS
Sight Sciences, Inc. - Common Stock
NASDAQ:SGHTNASDAQ
SGHT
Profound Medical Corp. - common stock
NASDAQ:PROFNASDAQ
PROF
Orchestra BioMed Holdings, Inc. - Ordinary Shares
NASDAQ:OBIONASDAQ
OBIO
Treace Medical Concepts, Inc. - Common Stock
NASDAQ:TMCINASDAQ
TMCI
Utah Medical Products, Inc. - Common Stock
NASDAQ:UTMDNASDAQ
UTMD
Pro-Dex, Inc. - Common Stock
NASDAQ:PDEXNASDAQ
PDEX
RxSight, Inc. - Common Stock
NASDAQ:RXSTNASDAQ
RXST
Embecta Corp. - Common Stock
NASDAQ:EMBCNASDAQ
EMBC
Sanara MedTech Inc. - Common Stock
NASDAQ:SMTINASDAQ
SMTI
Lucid Diagnostics Inc. - Common Stock
NASDAQ:LUCDNASDAQ
LUCD
TriSalus Life Sciences, Inc. - Common Stock
NASDAQ:TLSINASDAQ
TLSI
Anika Therapeutics Inc. - Common Stock
NASDAQ:ANIKNASDAQ
ANIK
Apyx Medical Corporation - Common Stock
NASDAQ:APYXNASDAQ
APYX
InfuSystems Holdings, Inc. Common Stock
AMEX:INFUAMEX
INFU
KORU Medical Systems, Inc. - Common Stock
NASDAQ:KRMDNASDAQ
KRMD
Stereotaxis, Inc. Common Stock
AMEX:STXSAMEX
STXS
Inogen, Inc - Common Stock
NASDAQ:INGNNASDAQ
INGN
CVRx, Inc. - Common Stock
NASDAQ:CVRXNASDAQ
CVRX
Hyperfine, Inc. - Class A Common Stock
NASDAQ:HYPRNASDAQ
HYPR
Owlet, Inc. Class A Common Stock
NYSE:OWLTNYSE
OWLT
NANO-X IMAGING LTD - Ordinary Shares
NASDAQ:NNOXNASDAQ
NNOX
Avita Medical, Inc. - Common Stock
NASDAQ:RCELNASDAQ
RCEL
SANUWAVE Health, Inc. - Common Stock
NASDAQ:SNWVNASDAQ
SNWV
Microbot Medical Inc. - Common Stock
NASDAQ:MBOTNASDAQ
MBOT
Fractyl Health, Inc. - Common Stock
NASDAQ:GUTSNASDAQ
GUTS
Vivani Medical, Inc. - Common Stock
NASDAQ:VANINASDAQ
VANI
Neuronetics, Inc. - Common Stock
NASDAQ:STIMNASDAQ
STIM
PolyPid Ltd. - Ordinary Shares
NASDAQ:PYPDNASDAQ
PYPD
Outset Medical, Inc. - Common Stock
NASDAQ:OMNASDAQ
OM
Neuraxis, Inc. Common Stock
AMEX:NRXSAMEX
NRXS
The Beauty Health Company - Class A Common Stock
NASDAQ:SKINNASDAQ
SKIN
electroCore, Inc. - Common Stock
NASDAQ:ECORNASDAQ
ECOR
LENSAR, Inc. - Common Stock
NASDAQ:LNSRNASDAQ
LNSR
Pulmonx Corporation - Common Stock
NASDAQ:LUNGNASDAQ
LUNG
Precision Optics Corporation, Inc. - Common stock
NASDAQ:POCINASDAQ
POCI
Xtant Medical Holdings, Inc. Common Stock
AMEX:XTNTAMEX
XTNT
Spectral AI, Inc. - Class A Common Stock
NASDAQ:MDAINASDAQ
MDAI
Nyxoah SA - Ordinary Shares
NASDAQ:NYXHNASDAQ
NYXH
DarioHealth Corp. - Common Stock
NASDAQ:DRIONASDAQ
DRIO
Baird Medical Investment Holdings Ltd - Ordinary Share
NASDAQ:BDMDNASDAQ
BDMD
Alpha Pro Tech, Ltd. Common Stock
AMEX:APTAMEX
APT
Envoy Medical, Inc. - Class A Common Stock
NASDAQ:COCHNASDAQ
COCH
Myomo Inc. Common Stock
AMEX:MYOAMEX
MYO
Heartbeam, Inc. - Common Stock
NASDAQ:BEATNASDAQ
BEAT
Sensus Healthcare, Inc. - Common Stock
NASDAQ:SRTSNASDAQ
SRTS
Nutriband Inc. - Common Stock
NASDAQ:NTRBNASDAQ
NTRB
InspireMD Inc. - Common Stock
NASDAQ:NSPRNASDAQ
NSPR
Accuray Incorporated - Common Stock
NASDAQ:ARAYNASDAQ
ARAY
PAVmed Inc. - Common Stock
NASDAQ:PAVMNASDAQ
PAVM
TELA Bio, Inc. - Common stock
NASDAQ:TELANASDAQ
TELA
Nephros, Inc. - Common Stock
NASDAQ:NEPHNASDAQ
NEPH
PLUS THERAPEUTICS, Inc. - Common Stock
NASDAQ:PSTVNASDAQ
PSTV
Milestone Scientific, Inc. Common Stock
AMEX:MLSSAMEX
MLSS
NeuroOne Medical Technologies Corporation - Common Stock
NASDAQ:NMTCNASDAQ
NMTC
Cytosorbents Corporation - Common Stock
NASDAQ:CTSONASDAQ
CTSO
Polyrizon Ltd. - Ordinary Shares
NASDAQ:PLRZNASDAQ
PLRZ
Picard Medical, Inc. Common Stock
AMEX:PMIAMEX
PMI
Modular Medical, Inc. - common stock
NASDAQ:MODDNASDAQ
MODD
Co-Diagnostics, Inc. - Common Stock
NASDAQ:CODXNASDAQ
CODX
Retractable Technologies, Inc. Common Stock
AMEX:RVPAMEX
RVP
Lifeward Ltd. - Ordinary Shares
NASDAQ:LFWDNASDAQ
LFWD
IRIDEX Corporation - Common Stock
NASDAQ:IRIXNASDAQ
IRIX
JIN MEDICAL INTERNATIONAL LTD. - Ordinary Shares
NASDAQ:ZJYLNASDAQ
ZJYL
Femasys Inc. - Common Stock
NASDAQ:FEMYNASDAQ
FEMY
Adagio Medical Holdings, Inc - Common Stock
NASDAQ:ADGMNASDAQ
ADGM
OSR Holdings, Inc. - Common Stock
NASDAQ:OSRHNASDAQ
OSRH
IceCure Medical Ltd. - Ordinary Shares
NASDAQ:ICCMNASDAQ
ICCM
Vivos Therapeutics, Inc. - Common Stock
NASDAQ:VVOSNASDAQ
VVOS
SeaStar Medical Holding Corporation - Common Stock
NASDAQ:ICUNASDAQ
ICU
Nexalin Technology, Inc. - Common Stock
NASDAQ:NXLNASDAQ
NXL
Check-Cap Ltd. - Ordinary Share
NASDAQ:MBAINASDAQ
MBAI
SiNtx Technologies, Inc. - Common Stock
NASDAQ:SINTNASDAQ
SINT
enVVeno Medical Corporation - Common Stock
NASDAQ:NVNONASDAQ
NVNO
Tenon Medical, Inc. - Common Stock
NASDAQ:TNONNASDAQ
TNON
Regentis Biomaterials Ltd. Ordinary Shares
AMEX:RGNTAMEX
RGNT
Cuprina Holdings (Cayman) Limited - Ordinary shares
NASDAQ:CUPRNASDAQ
CUPR
HeartSciences Inc. - Common Stock
NASDAQ:HSCSNASDAQ
HSCS
Intelligent Bio Solutions Inc. - Common Stock
NASDAQ:INBSNASDAQ
INBS
Innovative Eyewear, Inc. - Common Stock
NASDAQ:LUCYNASDAQ
LUCY
CollPlant Biotechnologies Ltd. - Ordinary Shares
NASDAQ:CLGNNASDAQ
CLGN
ENDRA Life Sciences Inc. - Common Stock
NASDAQ:NDRANASDAQ
NDRA
ENvue Medical, Inc. - Common Stock
NASDAQ:FEEDNASDAQ
FEED
Beyond Air, Inc. - Common Stock
NASDAQ:XAIRNASDAQ
XAIR
Bluejay Diagnostics, Inc. - Common Stock
NASDAQ:BJDXNASDAQ
BJDX
NexGel, Inc - Common Stock
NASDAQ:NXGLNASDAQ
NXGL
Autonomix Medical, Inc. - Common Stock
NASDAQ:AMIXNASDAQ
AMIX
GlucoTrack, Inc. - Common Stock
NASDAQ:GCTKNASDAQ
GCTK
SOBR Safe, Inc. - Common Stock
NASDAQ:SOBRNASDAQ
SOBR
INVO Fertility, Inc. - Common Stock
NASDAQ:IVFNASDAQ
IVF
Catheter Precision, Inc. Common Stock
AMEX:VTAKAMEX
VTAK
Aethlon Medical, Inc. - Common Stock
NASDAQ:AEMDNASDAQ
AEMD
Bone Biologics Corp - Common Stock
NASDAQ:BBLGNASDAQ
BBLG
Sonoma Pharmaceuticals, Inc. - Common Stock
NASDAQ:SNOANASDAQ
SNOA
Profusa, Inc. - Common Stock
NASDAQ:PFSANASDAQ
PFSA
Nuwellis, Inc. - Common Stock
NASDAQ:NUWENASDAQ
NUWE
WORK Medical Technology Group LTD - Class A Ordinary Shares
NASDAQ:WOKNASDAQ
WOK
Get AI analysis for Medical Devices & Diagnostics companies
Management credibility, business model strength, growth catalysts, and risk assessment with exact page citations.
Get started free